Why do conferences matter? You must never stop learning. You need to keep an eye on what everyone else is thinking, and you get to see in just a few days who are leading in any given space. Networking is key! Make sure you know who will be there, research them, meet then, collaborate with them -Come Join us for the Sleep and Wellness Conference Hosted by the American Sleep and … [Read more...] about SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
Sleep DT Blog
Snoring, American Sleep and Breathing Academy and the NY Times
What can be done about snoring In a recent is sue of the New York Times, snoring once again became national news. While the topic may seem a bit mundane for one of the nation’s newspapers of record, snoring and it’s possible comorbidities such as sleep apnea, are serious issues. American Sleep and Breathing Academy (ASBA) past president Dr. Kent Smith DDS is quoted in the … [Read more...] about Snoring, American Sleep and Breathing Academy and the NY Times
Jazz Pharma Presents 17 New Posters for SLEEP 2022
Jazz Pharmaceuticals announced that the company and its partners will present 17 new abstracts from across its neuroscience portfolio at SLEEP 2022, the 36th annual meeting of the Associated Professional Sleep Societies (APSS) being held June 4-8, 2022. "Our latest research being presented at SLEEP 2022 provides important insights that benefit people living with complex and … [Read more...] about Jazz Pharma Presents 17 New Posters for SLEEP 2022
AJMC Hypes SLEEP 2022
With SLEEP 2022 set to begin in Charlotte, N.C. on June 4, the American Journal of Managed Care contributed a bit of advance hype. The 36th annual meeting of the Associated Professional Sleep Societies (APSS) will run from June 4-8, 2022. AJMC reports that the APSS’ first in-person conference in two years will highlight a myriad of new research on clinical sleep medicine and … [Read more...] about AJMC Hypes SLEEP 2022
Avadel Pharmaceuticals’ Stock Falls
According to a report in FIERCE Biotech, Avadel Pharmaceuticals’ shares have gone down 48% to $1.72, compared to a prior close of $3.38. The drop came after approval for Avadel Pharmaceuticals’ narcolepsy drug was set back to 2023 due to a patent issue flagged by the FDA. “The company revealed the delay in a regulatory filing,” writes reporter Annalee Armstrong. “According … [Read more...] about Avadel Pharmaceuticals’ Stock Falls
